{
    "text": "Our results suggest that the combination of low dose cisplatin and scriptaid is cytotoxic to NSCLC lines, can overcome hypoxia induced resistance and mutant p53- induced instability often associated with this cancer, and has the potential to be an effective therapeutic modality.", 
    "denotations": [
        {
            "id": "T1", 
            "obj": "NSCLC", 
            "span": {
                "begin": 93, 
                "end": 98
            }
        }, 
        {
            "id": "T1", 
            "obj": "p53", 
            "span": {
                "begin": 157, 
                "end": 160
            }
        }
    ],
    "relations": [
        {
            "id":"R1",
            "pred":"causes",
            "subj":"T2", 
          "obj":"T1"}
    ]
}